Developer docs
API playgroundTry for free, no card

Search company profiles

Omega Medical

Full company profile

uuid0051h5z

Namestring
Omega Medical
Legal namestring
Omega Medical
Websiteurl
omegamedical.co
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Omega Medical is a Calabasas, California-based medical technology company founded in 2023 that supplies wound care, durable medical equipment (DME), and aesthetic products to healthcare professionals. Its stated focus is regenerative wound care, anchored by its flagship APIS® skin substitute — a proprietary formulation incorporating Manuka Honey — alongside a broader portfolio of skin substitutes and biologics, DME supplies for wound care, and aesthetic products intended to support post-procedure recovery and skin health. The company's mission is framed as supporting patient treatment until chronic wounds become a thing of the past, and its vision is to connect healthcare teams with innovative regenerative products and support services.

Operationally, Omega Medical runs a sales-led, direct-engagement go-to-market: products are sold directly to wound care specialists, healthcare teams, and clinical professionals, with the corporate website as the primary digital surface and a single phone number ((213) 254-9333) for inbound inquiries. Pricing is not publicly disclosed; customers are directed to contact the company. Revenue mechanics are described as one-time license/sale of skin substitutes and biologics and hardware sales for DME and aesthetic products. The company is privately held, has approximately 10 employees, has no disclosed funding rounds, no parent company, and no publicly named management team, customers, or regulatory certifications in the source material.

Short descriptiontext

Omega Medical is a Calabasas, CA-based medical technology company founded in 2023 that sells advanced wound care products — including its APIS® Manuka Honey skin substitute, other skin substitutes and biologics, DME supplies, and aesthetic products — directly to wound care specialists and healthcare professionals.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNot specified, United States
HQ citystring
Not specified
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
wound care products, skin substitutes, regenerative medicine, durable medical equipment, aesthetic medical supplies
Industry2 codes
1Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts)
CodeHLAHALAEPrimaryYes
2Wound Healing & Skin Regeneration (advanced dressings, skin substitutes)
CodeHLAAAGAGPrimaryNo
NAICS code1 code
  • Medical Equipment and Supplies Manufacturing3391
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Wound Care Medical Products
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Skin Substitutes and Biologics
TypeOne Time License
Description

Sale of advanced skin substitutes and biologics to healthcare providers and wound care specialists. These products support the body's natural healing process for chronic wounds.

omegamedical.com
2DME Supplies (Durable Medical Equipment)
TypeHardware Sales
Description

Sale of wound care supplies and DME products to healthcare professionals and patients, featuring new technologies and programs aimed at improving wound care outcomes.

omegamedical.com
3Aesthetic Products
TypeHardware Sales
Description

Sale of advanced aesthetic products designed to support superior outcomes and faster recovery after procedures, targeting skin health and beauty applications.

omegamedical.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Supply Chain, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1APIS®
Description

Skin Sub with Manuka Honey - Advanced skin substitute product

omegamedical.com
Core offering1 text field

Omega Medical provides advanced skin substitutes and biologics (including its proprietary APIS® skin substitute with Manuka Honey), durable medical equipment (DME) wound care supplies, and aesthetic products to healthcare professionals. The portfolio is designed to support chronic wound treatment, post-procedure recovery, and skin health applications, sold directly to wound care specialists and medical practices.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Omega Medical is a provider of advanced medical technology and unique products focused on wound care. Their portfolio includes APIS® (a skin substitute with Manuka Honey), advanced skin substitutes and biologics, durable medical equipment (DME) supplies, and aesthetic products. These offerings are designed to support healthcare professionals in addressing chronic wounds, promoting faster healing, and delivering superior patient outcomes.

Product and service4 records
1APIS® Skin Substitute with Manuka Honey
2Skin Substitutes and Biologics
3DME Supplies
4Aesthetic Products
Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Organogenesis is a leading US manufacturer of advanced wound care and skin substitute products (e.g., Apligraf, Dermagraft). It is the most directly comparable peer to Omega Medical given overlapping focus on biologic skin substitutes sold to wound care specialists.

TypeDirect peer
Description

Integra LifeSciences offers regenerative wound care technologies including Integra Dermal Regeneration Template and skin substitute products. It is a direct competitor in advanced wound care biologics and shares Omega Medical's hospital and specialty clinic sales motion.

TypeDirect peer
Description

MiMedx develops and markets regenerative skin and soft-tissue allografts (e.g., EpiFix, AmnioFix) used in wound care and surgical recovery. It directly competes with Omega Medical's APIS® and broader skin substitute portfolio in the chronic wound care channel.

TypeBroad incumbent
Description

Coloplast is a global wound care and ostomy manufacturer with advanced wound care dressings and skin management products. It is a broad incumbent competitor in the same wound care provider channel as Omega Medical.

TypeBroad incumbent
Description

Smith+Nephew is a global medical device incumbent with a large advanced wound care portfolio (e.g., PICO, ALLEVYN, skin substitute offerings). It competes broadly with Omega Medical in wound care, though it is not focused exclusively on skin substitutes like Omega.

TypeEmerging player
Description

PolyNovo is a smaller regenerative medicine company focused on dermal regeneration and wound care (e.g., NovoSorb BTM). It is comparable to Omega Medical as a niche, growth-stage peer in advanced wound and skin regeneration.

TypeDirect peer
Description

Amniox Medical / TissueTech markets biologic wound healing and surgical recovery products derived from amniotic membrane (e.g., CLARIX, NEOX). It is a direct peer in regenerative skin substitute and post-procedure tissue repair offerings.

TypeBroad incumbent
Description

Solventum (spun off from 3M Health Care) is a broad medical incumbent with a significant advanced wound care portfolio. It competes with Omega Medical in DME supplies and certain wound care categories, though it operates at vastly larger scale.

TypeEmerging player
Description

Bioventus offers orthobiologics and wound care solutions including skin substitute and soft tissue repair products following its Misonix acquisition. It is comparable to Omega Medical as a smaller, growth-stage biologics player in adjacent regenerative categories.

TypeBroad incumbent
Description

Convatec is a major wound care and ostomy player (e.g., AQUACEL) operating across advanced dressings and skin/soft-tissue management. It overlaps with Omega Medical's DME supplies and skin substitute categories as a broad incumbent.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Omega Medical

Wound Care Medical Productsomegamedical.co

Omega Medical is a Calabasas, CA-based medical technology company founded in 2023 that sells advanced wound care products — including its APIS® Manuka Honey skin substitute, other skin substitutes and biologics, DME supplies, and aesthetic products — directly to wound care specialists and healthcare professionals.

What Omega Medical does

Omega Medical is a Calabasas, California-based medical technology company founded in 2023 that supplies wound care, durable medical equipment (DME), and aesthetic products to healthcare professionals. Its stated focus is regenerative wound care, anchored by its flagship APIS® skin substitute — a proprietary formulation incorporating Manuka Honey — alongside a broader portfolio of skin substitutes and biologics, DME supplies for wound care, and aesthetic products intended to support post-procedure recovery and skin health. The company's mission is framed as supporting patient treatment until chronic wounds become a thing of the past, and its vision is to connect healthcare teams with innovative regenerative products and support services.

Operationally, Omega Medical runs a sales-led, direct-engagement go-to-market: products are sold directly to wound care specialists, healthcare teams, and clinical professionals, with the corporate website as the primary digital surface and a single phone number ((213) 254-9333) for inbound inquiries. Pricing is not publicly disclosed; customers are directed to contact the company. Revenue mechanics are described as one-time license/sale of skin substitutes and biologics and hardware sales for DME and aesthetic products. The company is privately held, has approximately 10 employees, has no disclosed funding rounds, no parent company, and no publicly named management team, customers, or regulatory certifications in the source material.

Omega Medical firmographics

Firmographics
Name
Omega Medical
Legal name
Omega Medical
Website
https://omegamedical.co
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
Omega Medical is a Calabasas, CA-based medical technology company founded in 2023 that sells advanced wound care products — including its APIS® Manuka Honey skin substitute, other skin substitutes and biologics, DME supplies, and aesthetic products — directly to wound care specialists and healthcare professionals.
Ownership category
akta.pro rank

Omega Medical industry classification

Industry
Product category
Wound Care Medical Products
NAICS
Medical Equipment and Supplies Manufacturing (3391)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts) (HLAHALAE)
akta.pro secondary industry
Wound Healing & Skin Regeneration (advanced dressings, skin substitutes) (HLAAAGAG)

Keywords

  • Wound care products
  • Skin substitutes
  • Regenerative medicine
  • Durable medical equipment
  • Aesthetic medical supplies

Where Omega Medical is headquartered

Location

Headquarters

HQ city
Not specified
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Omega Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

  1. Skin Substitutes and Biologics: Sale of advanced skin substitutes and biologics to healthcare providers and wound care specialists. These products support the body's natural healing process for chronic wounds.
  2. DME Supplies (Durable Medical Equipment): Sale of wound care supplies and DME products to healthcare professionals and patients, featuring new technologies and programs aimed at improving wound care outcomes.
  3. Aesthetic Products: Sale of advanced aesthetic products designed to support superior outcomes and faster recovery after procedures, targeting skin health and beauty applications.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Omega Medical product offering

Product offering

Core offering

Omega Medical provides advanced skin substitutes and biologics (including its proprietary APIS® skin substitute with Manuka Honey), durable medical equipment (DME) wound care supplies, and aesthetic products to healthcare professionals. The portfolio is designed to support chronic wound treatment, post-procedure recovery, and skin health applications, sold directly to wound care specialists and medical practices.

Product overview

Omega Medical is a provider of advanced medical technology and unique products focused on wound care. Their portfolio includes APIS® (a skin substitute with Manuka Honey), advanced skin substitutes and biologics, durable medical equipment (DME) supplies, and aesthetic products. These offerings are designed to support healthcare professionals in addressing chronic wounds, promoting faster healing, and delivering superior patient outcomes.

Differentiator

Problem solved

Functional benefit

Brands

  • APIS®: Skin Sub with Manuka Honey - Advanced skin substitute product

Products and services

  • APIS® Skin Substitute with Manuka Honey
  • Skin Substitutes and Biologics
  • DME Supplies
  • Aesthetic Products

Companies that use Omega Medical

Customer profile

Segments1 record

Ideal customer profiles1 record

Omega Medical technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Omega Medical partnerships and signals

Strategic signal

Recent moves4 records

Expansion highlights3 records

Omega Medical competitors and assessment

Company assessment

Direct peers

  • Organogenesis: Organogenesis is a leading US manufacturer of advanced wound care and skin substitute products (e.g., Apligraf, Dermagraft). It is the most directly comparable peer to Omega Medical given overlapping focus on biologic skin substitutes sold to wound care specialists.
  • Integra LifeSciences: Integra LifeSciences offers regenerative wound care technologies including Integra Dermal Regeneration Template and skin substitute products. It is a direct competitor in advanced wound care biologics and shares Omega Medical's hospital and specialty clinic sales motion.
  • MiMedx Group: MiMedx develops and markets regenerative skin and soft-tissue allografts (e.g., EpiFix, AmnioFix) used in wound care and surgical recovery. It directly competes with Omega Medical's APIS® and broader skin substitute portfolio in the chronic wound care channel.
  • Amniox Medical (TissueTech): Amniox Medical / TissueTech markets biologic wound healing and surgical recovery products derived from amniotic membrane (e.g., CLARIX, NEOX). It is a direct peer in regenerative skin substitute and post-procedure tissue repair offerings.

Broad incumbents

  • Coloplast: Coloplast is a global wound care and ostomy manufacturer with advanced wound care dressings and skin management products. It is a broad incumbent competitor in the same wound care provider channel as Omega Medical.
  • Smith+Nephew: Smith+Nephew is a global medical device incumbent with a large advanced wound care portfolio (e.g., PICO, ALLEVYN, skin substitute offerings). It competes broadly with Omega Medical in wound care, though it is not focused exclusively on skin substitutes like Omega.
  • 3M Health Care (Solventum): Solventum (spun off from 3M Health Care) is a broad medical incumbent with a significant advanced wound care portfolio. It competes with Omega Medical in DME supplies and certain wound care categories, though it operates at vastly larger scale.
  • Convatec: Convatec is a major wound care and ostomy player (e.g., AQUACEL) operating across advanced dressings and skin/soft-tissue management. It overlaps with Omega Medical's DME supplies and skin substitute categories as a broad incumbent.

Emerging players

  • PolyNovo: PolyNovo is a smaller regenerative medicine company focused on dermal regeneration and wound care (e.g., NovoSorb BTM). It is comparable to Omega Medical as a niche, growth-stage peer in advanced wound and skin regeneration.
  • Bioventus: Bioventus offers orthobiologics and wound care solutions including skin substitute and soft tissue repair products following its Misonix acquisition. It is comparable to Omega Medical as a smaller, growth-stage biologics player in adjacent regenerative categories.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

Omega Medical social profiles

Digital presence

Omega Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Omega Medical leadership team

Management profile

Number of profiles

Omega Medical funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Omega Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Omega Medical

What does Omega Medical do?

Omega Medical provides advanced skin substitutes and biologics (including its proprietary APIS® skin substitute with Manuka Honey), durable medical equipment (DME) wound care supplies, and aesthetic products to healthcare professionals. The portfolio is designed to support chronic wound treatment, post-procedure recovery, and skin health applications, sold directly to wound care specialists and medical practices.

Is Omega Medical a public or private company?

Omega Medical is a private company. It is classified as unknown and is currently operating.

When was Omega Medical founded?

Omega Medical was founded in -1. It employs 1 to 10 people.

Where is Omega Medical based?

Omega Medical is headquartered in Not specified, United States, in the North America region.

How does Omega Medical make money?

Three revenue lines are on record. Skin Substitutes and Biologics are the primary driver. The others are DME Supplies (Durable Medical Equipment) and aesthetic Products.

Who are Omega Medical's main competitors?

Direct peers on record are Organogenesis, Integra LifeSciences, MiMedx Group and Amniox Medical (TissueTech). Broad incumbents are Coloplast, Smith+Nephew, 3M Health Care (Solventum) and Convatec. Emerging players are PolyNovo and Bioventus.

Does Omega Medical have an API?

No public API is recorded for Omega Medical.

What industry is Omega Medical in?

Omega Medical's product category is Wound Care Medical Products. Its primary akta.pro industry code is HLAHALAE, Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts), with a secondary code of HLAAAGAG, Wound Healing & Skin Regeneration (advanced dressings, skin substitutes). Its NAICS code is 3391 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales